Timothy Keutzer
Fortune : 948 429 $ au 31/05/2026
Fortune : 948 429 $ au 31/05/2026
Timothy Keutzer is currently Chief Operating Officer at Spero Therapeutics, Inc. since 2023.
Formerly, Mr. Keutzer was Vice President-Program & Portfolio Management at Cubist Pharmaceuticals LLC from 2014 to 2015.
Mr. Keutzer completed undergraduate education at the University of Kentucky.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SPERO THERAPEUTICS, INC. 0,58 % | 01/04/2026 | 335 134 ( 0,58 % ) | 948 429 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Directeur des opérations | 01/02/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
| CUBIST PHARMACEUTICALS INC | Corporate Officer/Principal | 01/07/2015 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Cubist Pharmaceuticals LLC
Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
University of Kentucky
University of Kentucky Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spero Therapeutics, Inc.
Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national